Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Secondary Glioblastoma: Molecular and Clinical Factors That Affect Outcome After Malignant Progression of a Lower Grade Tumor.

World neurosurgery - 1 Jun 2017

Gessler Florian, Zappi Johannes, Konczalla Juergen, Bernstock Joshua D, Forster Marie-Therese, Wagner Marlies, Mittelbronn Michel, Seifert Volker, Senft Christian

Abstract excerpt

BACKGROUND AND OBJECTIVE: There is limited information on prognostic factors and outcomes in patients with secondary glioblastoma (sGBM). Herein we report on the outcomes of patients with sGBM and identify clinically relevant prognostic factors. METHODS: We retrospectively analyzed our institutional database for patients with histologic evidence of World Health Organization (WHO) grade II-III gliomas that went on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioblastoma

Share to Isocitrate Dehydrogenase

Share to Kaplan-Meier Estimate

Share to Magnetic Resonance Imaging

Share to Neoplasm Grading

Share to Statistics, Nonparametric

Source

Identifiers

PMID: 28263929
DOI: 10.1016/j.wneu.2017.02.104

Genes

IDH1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Secondary Glioblastoma: Molecular and Clinical Factors That Affect Outcome After Malignant Progression of a Lower Grade Tumor.PMID 28263929Read ↗

Secondary glioblastomas with IDH1/2 mutations have longer glioma history from preceding lower-grade gliomas.Semantic proximity Read ↗

Survival in patients with glioblastoma at a first progression does not correlate with isocitrate dehydrogenase (IDH)1 gene mutation status.Semantic proximity Read ↗

The definition of primary and secondary glioblastoma.Semantic proximity Read ↗

Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution.Semantic proximity Read ↗

IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.Semantic proximity Read ↗

The extent of resection and adjuvant treatment are beneficial to the outcome of secondary glioblastomaSemantic proximity Read ↗

IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma.Semantic proximity Read ↗

Isocitrate Dehydrogenase Mutations in Low-Grade Gliomas Correlate With Prolonged Overall Survival in Older Patients.Semantic proximity Read ↗

Insular primary glioblastomas with IDH mutations: Clinical and biological specificities.Semantic proximity Read ↗

Primary versus secondary gliosarcoma: a systematic review and meta-analysis.Semantic proximity Read ↗

Accelerated progression of IDH mutant glioma after first recurrenceSemantic proximity Read ↗

New molecular prognostic factors of adult diffuse lower-grade gliomas in post-2016 molecular era: a retrospective analysis from single center.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.